Catalio Capital Management, LP

Position in BMY — Bristol Myers Squibb Co

CIK 1958125 NEW YORK, NY

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,794,812

-$1,722,280 QoQ

Shares Held

412,961

-1.8% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

4.47%

of 13F equity value

Holder Rank

#256

of 2,514 holders

Holding Since

Dec 2024

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Catalio Capital Management, LP holds $93,107,426 across 3 Drug Manufacturers - General names. BMY ranks #3 (25.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	138,946	$35,288,115
2	GILD	Gilead Sciences, Inc.	269,309	$34,024,499
3	BMY	Bristol Myers Squibb Co This page	412,961	$23,794,812

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,794,812	412,961	-1.8%	Shares	Sole	2026-08-14
2026-03-31	$25,517,092	420,727	-35.1%	Shares	Sole	2026-05-15
2025-12-31	$34,947,672	647,899	+29.8%	Shares	Sole	2026-02-17
2024-12-31	$28,231,980	499,151	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.